Oxidative stress, NF-κB and the ubiquitin proteasomal pathway in the pathology of calpainopathy

Neurochemical Research

Volumn 38, Issue 10, 2013, Pages 2009-2018

  Rajakumar, Dhanarajan ^a   Alexander, Mathew ^a   Oommen, Anna ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Calpainopathy; Muscular dystrophy; Neuromuscular disorders; NF B; Oxidative stress; Ubiquitin proteasomal pathway

Indexed keywords

3 NITROTYROSINE; ATROGIN 1; CALPAIN 3; FREE RADICAL; GLUTATHIONE; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MUSCLE RING FINGER 1 PROTEIN; NITRIC OXIDE; NITRITE; NONCOLLAGEN PROTEIN; PROTEASOME; PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THIOL; TRANSCRIPTION FACTOR RELA; UBIQUITIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CALPAINOPATHY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; HUMAN; HUMAN TISSUE; LIMB GIRDLE MUSCULAR DYSTROPHY; LIPID PEROXIDATION; MUSCLE ATROPHY; MUSCLE BIOPSY; NITROCYSTEINYLATION; NITROSATIVE STRESS; NITROSYLATION; NITROTYROSINYLATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEPLETION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; S NITROSYLATION; UBIQUITINATION; UPREGULATION;

ADOLESCENT; CALPAIN; CHILD; HUMANS; I-KAPPA B KINASE; MUSCLES; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; NF-KAPPA B; NITRITES; OXIDATIVE STRESS; PROTEASOME ENDOPEPTIDASE COMPLEX; SIGNAL TRANSDUCTION; UBIQUITIN; YOUNG ADULT;

EID: 84884907406     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-013-1107-z     Document Type: Article

References (56)

1. Carter GT (2012) Rehabilitation management of neuromuscular disease. http://emedicine.medscape.com/article/321397-overview
2. Cohn RD, Campbell KP (2000) Molecular basis of muscular dystrophies. Muscle Nerve 23(10):1456-1471
3. Dhanarajan R, Anilkumar BP, Mathew A, Geeta C, Oommen A (2011) Degradation of myofibrillar proteins and inadequate antioxidants in selective muscle wasting of limb girdle muscular dystrophy. Int J Case Rep Images (IJCRI) 2(6):6-11
4. Baghdiguian S, Richard I, Martin M, Coopman P, Beckmann JS, Mangeat P, Lefranc G (2001) Pathophysiology of limb girdle muscular dystrophy type 2A: hypothesis and new insights into the IkappaBalpha/NF-kappaB survival pathway in skeletal muscle. J Mol Med 79(5-6):254-261
5. Khadilkar SV, Singh RK (2008) Limb girdle muscular dystrophies in India. Neurol India 56(3):281-288
6. Bushby KM (1999) Making sense of the limb-girdle muscular dystrophies. Brain 122:1403-1420
7. Richard I, Broux O, Allamand V, Fougerousse F, Chiannilkulchai N, Bourg N, Brenguier L, Devaud C, Pasturaud P, Roudaut C (1995) Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 81(1):27-40
8. Shin J-H, Kim H-S, Lee C-H, Kim C-M, Park K-H, Kim D-S (2007) Mutations of CAPN3 in Korean patients with limb-girdle muscular dystrophy. J Korean Med Sci 22(3):463-469
9. Pathak P, Sharma MC, Sarkar C, Jha P, Suri V, Mohd H, Singh S, Bhatia R, Gulati S (2010) Limb girdle muscular dystrophy type 2A in India: a study based on semi-quantitative protein analysis, with clinical and histopathological correlation. Neurol India 58(4):549-554
10. Kramerova I, Kudryashova E, Wu B, Germain S, Vandenborne K, Romain N, Haller RG, Verity MA, Spencer MJ (2009) Mitochondrial abnormalities, energy deficit and oxidative stress are features of calpain 3 deficiency in skeletal muscle. Hum Mol Genet 18(17):3194-3205
11. Tidball JG, Wehling-Henricks M (2007) The role of free radicals in the pathophysiology of muscular dystrophy. J Appl Physiol 102(4):1677-1686
12. Rando TA (2002) Oxidative stress and the pathogenesis of muscular dystrophies. Am J Phys Med Rehabil 81(11 Suppl):S175-S186
13. Ragusa RJ, Chow CK, Porter JD (1997) Oxidative stress as a potential pathogenic mechanism in an animal model of Duchenne muscular dystrophy. Neuromuscul Disord 7(6-7):379-386
14. Menazza S, Blaauw B, Tiepolo T, Toniolo L, Braghetta P, Spolaore B, Reggiani C, Di Lisa F, Bonaldo P, Canton M (2010) Oxidative stress by monoamine oxidases is causally involved in myofiber damage in muscular dystrophy. Hum Mol Genet 19(21):4207-4215
15. Macaione V, Aguennouz M, Rodolico C, Mazzeo A, Patti A, Cannistraci E, Colantone L, Di Giorgio RM, De Luca G, Vita G (2007) RAGE-NF-kappaB pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy. Acta Neurol Scand 115(2):115-121
16. Lawler JM (2011) Exacerbation of pathology by oxidative stress in respiratory and locomotor muscles with Duchenne muscular dystrophy. J Physiol 589(Pt 9):2161-2170
17. Bakkar N, Guttridge DC (2010) NF-κB signaling: a tale of two pathways in skeletal myogenesis. Physiol Rev 90(2):495-511
18. Wyke SM, Tisdale MJ (2005) NF-kappaB mediates proteolysis-inducing factor induced protein degradation and expression of the ubiquitin-proteasome system in skeletal muscle. Br J Cancer 92(4):711-721
19. Acharyya S, Villalta SA, Bakkar N et al (2007) Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J Clin Invest 117(4):889-901
20. Cai D, Frantz JD, Tawa NE Jr et al (2004) IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 119(2):285-298
21. Baghdiguian S, Martin M, Richard I et al (1999) Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkappaB alpha/NF-kappaB pathway in limb-girdle muscular dystrophy type 2A. Nat Med 5(5):503-511
22. Mourkioti F, Kratsios P, Luedde T, Song Y-H, Delafontaine P, Adami R, Parente V, Bottinelli R, Pasparakis M, Rosenthal N (2006) Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration. J Clin Invest 116(11):2945-2954
23. Wysong A, Couch M, Shadfar S et al (2011) NF-κB inhibition protects against tumor-induced cardiac atrophy in vivo. Am J Pathol 178(3):1059-1068
24. Messina S, Altavilla D, Aguennouz M et al (2006) Lipid peroxidation inhibition blunts nuclear factor-kappaB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice. Am J Pathol 168(3):918-926
25. Whitehead NP, Yeung EW, Froehner SC, Allen DG (2010) Skeletal muscle NADPH oxidase is increased and triggers stretch-induced damage in the mdx mouse. PLoS ONE 5(12):e15354
26. Javesghani D, Magder SA, Barreiro E, Quinn MT, Hussain SNA (2002) Molecular characterization of a superoxide-generating NAD(P)H oxidase in the ventilatory muscles. Am J Respir Crit Care Med 165(3):412-418
27. Mofarrahi M, Brandes RP, Gorlach A, Hanze J, Terada LS, Quinn MT, Mayaki D, Petrof B, Hussain SNA (2008) Regulation of proliferation of skeletal muscle precursor cells by NADPH oxidase. Antioxid Redox Signal 10(3):559-574
28. Renjini R, Gayathri N, Nalini A, Srinivas Bharath MM (2012) Oxidative damage in muscular dystrophy correlates with the severity of the pathology: role of glutathione metabolism. Neurochem Res 37(4):885-898
29. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95(2):351-358
30. Yucel D, Aydogdu S, Cehreli S, Saydam G, Canatan H, Senes M, Topkaya BC, Nebioglu S (1998) Increased oxidative stress in dilated cardiomyopathic heart failure. Clin Chem 44(1):148-154
31. Herrera B, Murillo MM, Alvarez-Barrientos A, Beltrán J, Fernández M, Fabregat I (2004) Source of early reactive oxygen species in the apoptosis induced by transforming growth factor-beta in fetal rat hepatocytes. Free Radic Biol Med 36(1):16-26
32. Sastry KVH, Moudgal RP, Mohan J, Tyagi JS, Rao GS (2002) Spectrophotometric determination of serum nitrite and nitrate by copper-cadmium alloy. Anal Biochem 306(1):79-82
33. Tidball JG, Wehling-Henricks M (2007) The role of free radicals in the pathophysiology of muscular dystrophy. J Appl Physiol 102(4):1677-1686
34. Powers SK, Talbert EE, Adhihetty PJ (2011) Reactive oxygen and nitrogen species as intracellular signals in skeletal muscle. J Physiol 589(Pt 9):2129-2138
35. Hochstrasser M (1992) Ubiquitin and intracellular protein degradation. Curr Opin Cell Biol 4(6):1024-1031
36. Kar NC, Pearson CM (1979) Catalase, superoxide dismutase, glutathione reductase and thiobarbituric acid-reactive products in normal and dystrophic human muscle. Clin Chim Acta 94(3):277-280
37. Foletta VC, White LJ, Larsen AE, Léger B, Russell AP (2011) The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy. Pflugers Arch 461(3):325-335
38. Anderson JE (2000) A role for nitric oxide in muscle repair: nitric oxide - mediated activation of muscle satellite cells. Mol Biol Cell 11(5):1859-1874
39. Rando TA (2001) Role of nitric oxide in the pathogenesis of muscular dystrophies: a "two hit" hypothesis of the cause of muscle necrosis. Microsc Res Tech 55(4):223-235
40. Brenman JE, Chao DS, Xia H, Aldape K, Bredt DS (1995) Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 82(5):743-752
41. Li D, Yue Y, Lai Y, Hakim CH, Duan D (2010) Nitrosative stress elicited by nNOSμ delocalization inhibits muscle force in dystrophin-null mice. J Pathol. doi: 10.1002/path.2799
42. Buck M, Chojkier M (1996) Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. EMBO J 15(8):1753-1765
43. Marshall HE, Merchant K, Stamler JS (2000) Nitrosation and oxidation in the regulation of gene expression. FASEB J 14(13):1889-1900
44. Wang Y-Y, Lin S-Y, Chuang Y-H, Mao C-H, Tung K-C, Sheu WH-H (2010) Protein nitration is associated with increased proteolysis in skeletal muscle of bile duct ligation-induced cirrhotic rats. Metab Clin Exp 59(4):468-472
45. Bellinger AM, Reiken S, Carlson C, Mongillo M, Liu X, Rothman L, Matecki S, Lacampagne A, Marks AR (2009) Hypernitrosylated ryanodine receptor/calcium release channels are leaky in dystrophic muscle. Nat Med 15(3):325-330
46. Foster MW, Hess DT, Stamler JS (2009) Protein S-nitrosylation in health and disease: a current perspective. Trends Mol Med 15(9):391-404
47. Dodd SL, Gagnon BJ, Senf SM, Hain BA, Judge AR (2010) Ros-mediated activation of NF-kappaB and Foxo during muscle disuse. Muscle Nerve 41(1):110-113
48. Shang F, Taylor A (2011) Ubiquitin-proteasome pathway and cellular responses to oxidative stress. Free Radic Biol Med 51(1):5-16
49. Caron AZ, Haroun S, Leblanc E, Trensz F, Guindi C, Amrani A, Grenier G (2011) The proteasome inhibitor MG132 reduces immobilization-induced skeletal muscle atrophy in mice. BMC Musculoskelet Disord 12:185
50. Kimura N, Kumamoto T, Oniki T, Nomura M, Nakamura K, Abe Y, Hazama Y, Ueyama H (2009) Role of ubiquitin-proteasome proteolysis in muscle fiber destruction in experimental chloroquine-induced myopathy. Muscle Nerve 39(4):521-528
51. Tisdale MJ (2005) The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting. J Support Oncol 3(3):209-217
52. Edström E, Altun M, Hägglund M, Ulfhake B (2006) Atrogin-1/MAFbx and MuRF1 are downregulated in aging-related loss of skeletal muscle. J Gerontol A Biol Sci Med Sci 61(7):663-674
53. Eddins MJ, Marblestone JG, Suresh Kumar KG, Leach CA, Sterner DE, Mattern MR, Nicholson B (2011) Targeting the ubiquitin E3 ligase MuRF1 to inhibit muscle atrophy. Cell Biochem Biophys 60(1-2):113-118
54. Lecker SH (2003) Ubiquitin-protein ligases in muscle wasting: multiple parallel pathways? Curr Opin Clin Nutr Metab Care 6(3):271-275
55. Lagirand-Cantaloube J, Cornille K, Csibi A, Batonnet-Pichon S, Leibovitch MP, Leibovitch SA (2009) Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo. PLoS ONE 4(3):e4973
56. Baehr LM, Furlow JD, Bodine SC (2011) Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids. J Physiol 589(19):4759-4776